Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

IL-33 Therapy Prevents Acute Lung Injury after Transplantation Via IL-9-Producing Type 2 Innate Lymphoid Cells Induction

Hua Jiang, PhD, Abdulraouf Ramadan, PhD, Becquet Laurine, MS, Tu Szu-Wei, Hong Liu, MS, Courtney Rowan, MD, Xiaowen Liu, PhD, Huanmei Wu, PhD, Jun Wan, PhD, Sophie Paczesny, MD PhD

Blood (2019) 134 (Supplement_1): 583.

https://doi.org/10.1182/blood-2019-123821

Published: 2019

Journal Articles

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

Blood (2018) 132 (Supplement 1): 312.

https://doi.org/10.1182/blood-2018-99-115276

Published: 2018

Journal Articles

ST2 and ROR-γ-t Roles in Intestinal Regulatory T Cells

Jinfeng Yang, PhD, Abdulraouf Ramadan, PhD, Dawn Reichenbach, PhD, Michael Loschi, MD, Jilu Zhang, PhD, Brad Griesenauer, PhD, Hong Liu, MS, Keli Lee Hippen, PhD, Bruce R. Blazar, MD, Sophie Paczesny, MD PhD

Blood (2018) 132 (Supplement 1): 66.

https://doi.org/10.1182/blood-2018-99-113003

Published: 2018

Journal Articles

ICOSL + Plasmacytoid Dendritic Cells As Biomarker and Inducer of Graft-Versus-Host Disease

Djamilatou Adom, PhD, Abdulraouf Ramadan, PhD, Kushi Kushekhar, PhD MSc, Sophie Paczesny, MD PhD

Blood (2018) 132 (Supplement 1): 355.

https://doi.org/10.1182/blood-2018-99-116417

Published: 2018

Journal Articles

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Michael R Verneris, MD, Tao Wang, PhD, Stephen R. Spellman, Jennifer A. Sees, MPH, Michael D. Haagenson, MS, Sarah Cooley, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, Katharina Fleischhauer, Dean Anthony Lee, MD PhD, Sophie Paczesny, MD PhD, Hemalatha G. Rangarajan, MD, Jeffrey S. Miller, MD, Stephanie J. Lee, MD MPH

Blood (2018) 132 (Supplement 1): 4647.

https://doi.org/10.1182/blood-2018-99-116428

Published: 2018

Journal Articles

The Role of HLA-E Polymorphism in Acute Leukemia Patients Receiving a 10/10 HLA Matched Unrelated HSCT

Chrysanthi Tsamadou, MD, Tao Wang, PhD, Daniel Fürst, MD PhD, Stephanie J. Lee, MD MPH, Stephen R. Spellman, Katharina Fleischhauer, Katharine C. Hsu, MD PhD, Sophie Paczesny, MD PhD, Michael R Verneris, MD, Christine Neuchel, PhD, Hubert Schrezenmeier, MD, Joannis Mytilineos, MD PhD

Blood (2018) 132 (Supplement 1): 310.

https://doi.org/10.1182/blood-2018-99-113432

Published: 2018

Journal Articles

Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo

Chao-Yie Yang, PhD, Abdulraouf Ramadan, PhD, Etienne Daguindau, MD, Jilu Zhang, PhD, Zachary Bolten, Krishnapriya Chinnaswamy, MS, Jeanne Stuckey, PhD, Sophie Paczesny, MD PhD

Blood (2016) 128 (22): 528.

https://doi.org/10.1182/blood.V128.22.528.528

Published: 2016

Journal Articles

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

Abdulraouf Ramadan, PhD, Jilu Zhang, PhD, Mohammad Abu Zaid, MD, Heather O'Leary, PhD, Reuben Kapur, PhD, Helmut Hanenberg, MD, Jie Sun, PhD, Hal E. Broxmeyer, PhD, Mark H. Kaplan, PhD, Sophie Paczesny, MD PhD

Blood (2015) 126 (23): 231.

https://doi.org/10.1182/blood.V126.23.231.231

Published: 2015

Journal Articles

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Sachiko Seo, MD PhD, Jeffrey Yu, Isaac C Jenkins, MS, Terry L Stevens-Ayers, MS, Kuypers M Jane, PhD, Huang Meei-Li, PhD, Wendy M Leisenring, PhD, Keith R Jerome, MD PhD, Sophie Paczesny, MD PhD, Michael Boeckh, MD

Blood (2015) 126 (23): 1927.

https://doi.org/10.1182/blood.V126.23.1927.1927

Published: 2015

Journal Articles

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Christen L Mumaw, BS, Ayman Akil, PhD, Nieves Velez de Mendizabal, PhD, Qing Zhang, Nisha Raiker, BS, Jeffrey Yu, Maribel Diaz-Ricart, PhD, Enric Carreras, MD, Laura S. Haneline, MD, Kent A. Robertson, MD PhD, Lindsey Elmore, Rose Case, Jamie Renbarger, MD, Samir Hanash, MD PhD, Robert R. Bies, PhD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 663.

https://doi.org/10.1182/blood.V124.21.663.663

Published: 2014

Journal Articles

Baseline Body Mass Index Among Children and Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: Clinical Characteristics and Outcomes

Michael Gleimer, PhD, Yumeng Li, MS, Lawrence Chang, MS, MD, Sophie Paczesny, MD PhD, David Hanauer, MS, MD, David Frame, PhD, Craig A. Byersdorfer, MD PhD, Pavan Reddy, MD, Thomas M. Braun, PhD, Sung Won Choi, MS, MD

Blood (2014) 124 (21): 2558.

https://doi.org/10.1182/blood.V124.21.2558.2558

Published: 2014

Journal Articles

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

Wei Li, PhD, Liangyi Liu, Aurelie Gomez, MD, Qing Zhang, Jilu Zhang, PhD, Abdulraouf Ramadan, PhD, Christen L Mumaw, BS, Joel K. Greenson, MD, Suntrea Hammer, MD, Jingmei Lin, MD PhD, Thomas M. Braun, PhD, Di Jiang, Elizabeth Virts, PhD, Stephanie L Kelich, Hong Wei Chu, MD PhD, Samir Hanash, MD PhD, Helmut Hanenberg, MD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 3.

https://doi.org/10.1182/blood.V124.21.3.3

Published: 2014

Journal Articles

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Doris M Ponce, MD, Patrick Hilden, MS, Christy Mumaw, MS, Sean Devlin, PhD, Marissa N Lubin, BA, Katherine L Evans, BA, Susan Prockop, MD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD, PhD, Sophie Paczesny, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 146.

https://doi.org/10.1182/blood.V122.21.146.146

Published: 2013

Journal Articles

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Carrie L Kitko, Rima M Saliba, PhD, Sophie Paczesny, MD, PhD., Maggi Kennel, BS, MS, Sung W. Choi, M.D., Pavan Reddy, M.D., John E. Levine, M.D., M.S., Daniel R. Couriel, M.D.

Blood (2012) 120 (21): 1941.

https://doi.org/10.1182/blood.V120.21.1941.1941

Published: 2012

Journal Articles

Discovery and Validation of Graft-Versus-Host Disease Biomarkers

Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): SCI-50.

https://doi.org/10.1182/blood.V118.21.SCI-50.SCI-50

Published: 2011

Journal Articles

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Mark T. Vander Lugt, M.D., Thomas Braun, PhD, James L.M. Ferrara, MD, DSc, Samir Hanash, M.D., Ph.D., John E. Levine, MD, MS, Chee-Hong Wang, Qing Zhang, Alice Chin, Andrew C. Harris, M.D., Sung W.J. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): 152.

https://doi.org/10.1182/blood.V118.21.152.152

Published: 2011

Journal Articles

A Novel Grading System of Lower Gastrointestinal Acute Graft-Versus-Host Disease At Disease Onset Predicts Response to Therapy and Non-Relapse Mortality

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Joel K. Greenson, M.D., Thomas M. Braun, Ph.D., Ernst Holler, M.D., Takanori Teshima, M.D., Ph.D., John E. Levine, M.D., M.S., Sung W.J. Choi, M.D., Elisabeth Huber, M.D., Karin Landfried, M.D., Koichi Akashi, MD, PhD., Mark T. Vander Lugt, M.D., Pavan Reddy, M.D., Alice Chin, Qing Zhang, Samir Hanash, M.D., Ph.D., Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): 153.

https://doi.org/10.1182/blood.V118.21.153.153

Published: 2011

Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Blood (2010) 116 (21): 675.

https://doi.org/10.1182/blood.V116.21.675.675

Published: 2010

Journal Articles

Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

John M. Magenau, MD, Xuemei Qin, MD, Isao Tawara, MD, PhD, Clare E Rogers, MS, Matthew Schlough, Daniel Bickley, Pil Sang Jang, MD, Thomas M Braun, PhD, Kathleen Lowler, Dawn M Jones, RN, Sung W Choi, MD, Shin Mineishi, MD, John E. Levine, MD, James LM Ferrara, MD, DSc, Sophie Paczesny, MD, PhD

Blood (2009) 114 (22): 514.

https://doi.org/10.1182/blood.V114.22.514.514

Published: 2009

Journal Articles

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Blood (2009) 114 (22): 43.

https://doi.org/10.1182/blood.V114.22.43.43

Published: 2009

NARROW

IL-33 Therapy Prevents Acute Lung Injury after Transplantation Via IL-9-Producing Type 2 Innate Lymphoid Cells Induction

Multiple Functional Donor Polymorphisms in IL1RL1 region Associate with Death Due to GvHD or Infection after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for AML and MDS

ST2 and ROR-γ-t Roles in Intestinal Regulatory T Cells

ICOSL + Plasmacytoid Dendritic Cells As Biomarker and Inducer of Graft-Versus-Host Disease

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

The Role of HLA-E Polymorphism in Acute Leukemia Patients Receiving a 10/10 HLA Matched Unrelated HSCT

Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo

IL-33/ST2 Triggering of IL-9-Secreting T Cells Alters the Balance of Fatal Immunity and Tumor Immunity

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Baseline Body Mass Index Among Children and Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: Clinical Characteristics and Outcomes

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Discovery and Validation of Graft-Versus-Host Disease Biomarkers

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

A Novel Grading System of Lower Gastrointestinal Acute Graft-Versus-Host Disease At Disease Onset Predicts Response to Therapy and Non-Relapse Mortality

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only